Orchard Therapeutics plc CEO Bobby Gaspar's 2020 pay jumps 311% to $3.8M
Orchard Therapeutics plc reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Orchard Therapeutics plc reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, three executives at Orchard Therapeutics plc received on average a compensation package of $3.3M, a 48% increase compared to previous year.
Average pay of disclosed executives at Orchard Therapeutics plc
Bobby Gaspar, Chief Executive Officer, received $3.8M in total, which increased by 311% compared to 2019. 81% of Gaspar's compensation, or $3.1M, was in option awards. Gaspar also received $170K in non-equity incentive plan and $543K in salary.
Mark Rothera, Chief Executive Officer, received a compensation package of $3.2M, which decreased by 26% compared to previous year. 77% of the compensation package, or $2.4M, was in option awards.
Frank Thomas, Chief Operating Officer, earned $3M in 2020, a 100% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2021.